Posted inPandemic-Response Treatment Protocol
Remdesivir
Remdesivir is "a nucleotide analogue prodrug that inhibits viral RNA polymerases," (an intravenous anti-viral drug) made by Gilead Sciences that was pulled from an Ebola trial due to it increasing mortality. [2] Dr Bryan Ardis in early 2020 looked into…